Pfizer Inc. (NYSE: PFE) today announced updated follow-up results from the single-arm Phase 2 PHAROS trial evaluating ...

Background Many observational studies highlight clonal haematopoiesis (CH) as a novel determinant of cardiovascular disease ...

Scientists at UCSF identified a key cellular switch that plays a large role in pulmonary fibrosis, and found a way of ...

Researchers developed PVC, a measure that estimates the reduced function of the pulmonary arteries in pediatric PAH patients, ...

Positive results from the POTOMAC Phase III trial showed adding one year of treatment with AstraZeneca's IMFINZI® (durvalumab) to BCG induction and maintenance therapy demonstrated a statistically ...

If Approved, BRINSUPRI Would Be the First and Only Treatment in the European Union for Non-Cystic Fibrosis Bronchiectasis ...

Pulmonary fibrosis is a deadly disease in which the lungs become thickened and scarred, gradually losing their ability to ...

Pulmonary fibrosis is a deadly disease in which the lungs become thickened and scarred, gradually losing their ability to ...

A female infant presented with a month-long history of dry cough, along with two episodes of fever and increased work of ...

The funding includes an initial tranche of $7.5 million in equity and technical support, and the biotech and foundation will form a joint steering committee.

Rx, a digital medicine company specialising in pulmonary care, has announced the launch of pDx, a mobile and web-accessible ...